Piscuoglio, Salvatore; Lehmann, Frank S; Zlobec, Inti; Tornillo, Luigi; Dietmaier, Wolfgang; Hartmann, Arndt; Wünsch, Peter H; Sessa, Fausto; Rümmele, Petra; Baumhoer, Daniel; Terracciano, Luigi M (2012). Effect of EpCAM, CD44, CD133 and CD166 expression on patient survival in tumours of the ampulla of Vater. Journal of clinical pathology, 65(2), pp. 140-5. London: BMJ Publishing Group 10.1136/jclinpath-2011-200043
Full text not available from this repository. (Request a copy)Carcinomas of the Vaterian system are rare and presumably arise from pre-existing adenomas. According to the cancer stem cell (CSC) hypothesis, only a small subset of tumor cells has the ability to initiate and develop tumor growth. In colorectal cancer, CD44, CD133, CD166 and EpCAM have been proposed to represent CSC marker proteins and their expression has been shown to correlate with patient survival.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Service Sector > Institute of Pathology |
UniBE Contributor: |
Zlobec, Inti |
ISSN: |
0021-9746 |
Publisher: |
BMJ Publishing Group |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:32 |
Last Modified: |
05 Dec 2022 14:10 |
Publisher DOI: |
10.1136/jclinpath-2011-200043 |
PubMed ID: |
22130902 |
Web of Science ID: |
000299821200009 |
URI: |
https://boris.unibe.ch/id/eprint/12505 (FactScience: 218857) |
Actions (login required)
 |
Edit item |